Nuveen Asset Management, LLC Bristol Myers Squibb CO Transaction History
Nuveen Asset Management, LLC
- $345 Billion
- Q3 2024
A detailed history of Nuveen Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 8,976,123 shares of BMY stock, worth $520 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
8,976,123
Previous 5,541,941
61.97%
Holding current value
$520 Million
Previous $230 Million
101.83%
% of portfolio
0.13%
Previous 0.07%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,532Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.9 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.18 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.38 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.51 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.53 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $123B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...